National consensus of management patients with abnormal uterine bleeding by association of gynecologist and endocrinologist of Ukraine
DOI:
https://doi.org/10.18370/2309-4117.2015.21.7-14Keywords:
abnormal uterine bleeding, PA LM-COE IN classification, hormone therapy, nonhormonal therapy, surgical treatmentAbstract
Current classification of abnormal uterine bleeding, review of diagnostic methods and treatment strategies of the condition are presented in the article. Moreover, evidence based algorithms of the diagnosis and treatment of this condition considering the features of the health care system in Ukraine are given
References
- Munro, M.G. Abnormal uterine bleeding. Cambridge: Cambridge University Press (2010).
- National Collaborating Centre for Women’s and Children’s Health; National Institute for Health and Care Excellence. NICE guideline CG44: heavy menstrual bleeding. London: Royal College of Obstetricians and Gynaecologists (2007).
- Fraser, I.S., Warner, P., Marantos, P.A. “Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume.” Obstet Gynecol, 98(5 Pt 1) (2001): 806–814.
- “Management of acute abnormal uterine bleeding in non-pregnant women“. Committee Opinion № 557. American College of Obstetricians and Gynecologists. Obstet Gynecol, 121(2013): 891–896.
- Breymann, C. J. Perinat Med, 38(2010).
- Lethaby, A., Augwood, C., Duckitt, K., Farquhar, C. “Nonsteroidal anti- inflammatory drugs for heavy menstrual bleeding.” Cochrane Database Syst Rev, 4(2007): CD000400.
- Hall, P., MacLachlan, N., Thorn, N., Nudd, M.W.E., Taylor, G.G., Garrioch, D.B. “Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid.” BJOG, 94(1987): 554–558.
- Gleeson, N., Buggy, F., Sheppard, B.L. “The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.” Acta Obstet Gynecol Scand, 73(1994): 274–277.
- Lethaby, A., Farhuhar, C., Cooke, I. “Antifibrinolytics for heavy menstrual bleeding.” Cochrane Database Syst Rev, 4(2000): CD000249.
- Ong, Y.L., Hull, D.R., Mayne, E.E. “Menorrhagia in von Willebrand disease successfully treated with single daily dose tranexamicacid.” Haemophilia, 4(1998): 63–65.
- Farquhar, C., Brown, J. “Oral contraceptive pill for heavy menstrual bleeding.” Cochrane Database Syst Rev, 4(2009):CD000154.
- Fraser, I.S., McCarron, G. “Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia.” Aust N Z J Obstet Gynaecol, 31(1991): 66–70.
- Nappi, R.E. “Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature.” Int J Womens Health, 6(2014): 711–718.
- Stewart, F.H., Kaunitz, A.M., Laguardia, K.D. “Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.” Obstet Gynecol, 105(2005): 1389–1396.
- Lethaby, A., Irvine, G.A., Cameron, I.T. “Cyclical progestogens for heavy menstrual bleeding.” Cochrane Database Syst Rev, 1(2008):CD001016.
- Irvine, G.A., Campbell-Brown, M.B., Lumsden, M.A, Heikkila, A., Walker, J.J., Cameron, I.T. “Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.” BJOG, 105(1998): 592–598.
- Marjoribanks, J., Lethaby, A., Farquhar, C. “Surgery versus medical therapy for heavy menstrual bleeding.” Cochrane Database Syst Rev, 2(2006): CD003855.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2015 В. М. Запорожан, Т. Ф. Татарчук, А. Бер, Н. В. Авраменко, О. В. Булавенко, Ю. П. Вдовиченко, І. Ю. Ганжий, Н. І. Геник, О. В. Грищенко, А. М. Громова, О. В. Демченко, З. М. Дубоссарська, О. О. Єфименко, Н. Я. Жилка, В. П. Квашенко, Н. В. Косей, Л. Б. Маркін, В. І. Медведь, Н. Ю. Педаченко, Н. М. Рожковська, Г. Б. Семеніна
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.